Hans-Peter Gerber

Insider Reports History

Entity
Individual
Location
C/O Sutro Biopharma, Inc., 111 Oyster Point Boulevard, South San Francisco, CA
Signature
/s/ David Pauling as attorney-in-fact for Hans-Peter Gerber
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hans-Peter Gerber:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SUTRO BIOPHARMA, INC. CHIEF SCIENTIFIC OFFICER Restricted Stock Units (RSUs) 114K $155K $1.36 Apr 4, 2025 Direct
SUTRO BIOPHARMA, INC. CHIEF SCIENTIFIC OFFICER Common Stock 30.7K $48.9K $1.59 Mar 1, 2025 Direct
SUTRO BIOPHARMA, INC. CHIEF SCIENTIFIC OFFICER Stock Option (Right to Buy) 123K Apr 4, 2025 Direct

Insider Reports Filed by Hans-Peter Gerber

Symbol Company Period Transactions Value $ Form Type Date Filed Role
STRO SUTRO BIOPHARMA, INC. Apr 4, 2025 2 $0 4 Apr 8, 2025 CHIEF SCIENTIFIC OFFICER
STRO SUTRO BIOPHARMA, INC. Mar 1, 2025 3 -$7.35K 4 Mar 4, 2025 CHIEF SCIENTIFIC OFFICER
STRO SUTRO BIOPHARMA, INC. Sep 18, 2024 3 -$52.9K 4 Sep 20, 2024 CHIEF SCIENTIFIC OFFICER
STRO SUTRO BIOPHARMA, INC. Mar 5, 2024 2 $0 4 Mar 7, 2024 CHIEF SCIENTIFIC OFFICER
STRO SUTRO BIOPHARMA, INC. Sep 18, 2023 2 $0 4 Sep 19, 2023 Chief Scientific Officer
STRO SUTRO BIOPHARMA, INC. Sep 18, 2023 0 $0 3 Sep 19, 2023 Chief Scientific Officer